Rebalix
Logo InvescoInvesco · sheet of 10 September 2026
ETF sheet · official issuer and register data

Invesco MSCI Europe Ex UK Universal Screened UCITS ETF Acc

ESEU · IE00BMDBMW94 · class Acc · EUR · domicile Ireland
Equity · EuropeSFDR art. 8
Index tracked: MSCI Europe ex UK Universal Select Business Screens Index
TER
0.16%+ trans. 0.02%
Fund size
11 m EUR
Tracking difference
+0.20%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 10 Mar 2021 · costs from the KID as of 14 Aug 2026 · 295 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The investment objective of the Fund is to achieve the net total return performance of the MSCI Europe Ex UK Universal Select Business Screens Index (the "Index"), less fees, expenses and transaction costs. Dividend Policy: This Share Class does not pay you income, but instead reinvests it to grow your capital, in line with its stated objectives. Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock…

Performance since series start (in euro) — base 100

10 Mar 202123 Jul 2026 · dividends reinvested where declared by the issuer
2022202320242025202617892173
High 178 (3 Jul 2026) · low 92 (29 Sept 2022) · last 173. Past performance is not indicative of future results.

Returns in euro

1 year+21.3%
3 years+47.9%
5 years+55.8%
10 yearsseries too young
Since series start+73.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.04%13.11%14.79%
Max drawdown−10.20%−16.38%−23.71%
Sharpe1.380.910.48
Sortino2.161.290.68
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ESEU · IE00BMDBMW941
RebalixESEU · IE00BMDBMW94 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+18.20%+17.97%+0.23%
2024+8.25%+8.07%+0.18%
2023+18.77%+18.59%+0.18%
2022−13.92%−14.04%+0.12%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 295 securities · top-10 weight = 28.6%
Top holdingsWeight
ASML HOLDING NV EUR0.095.4%
ROCHE HOLDINGS AG CHF NPV3.4%
NOVARTIS AG-REG CHF0.53.3%
NESTLE SA-REG CHF0.12.8%
SIEMENS AG-REG NPV2.7%
SAP SE NPV2.5%
BANCO SANTANDER SA EUR0.52.3%
ALLIANZ SE-REG NPV2.2%
TOTAL ENERGIES SE EUR2.52.0%
UBS GROUP AG-REG CHF 0.10001.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
ESGX · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BMDBMW94
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · ESEU · IE00BMDBMW942